Optimi Health Corp. (OPTH)
NASDAQ: OPTH · Real-Time Price · USD
5.64
-0.33 (-5.53%)
At close: Jun 1, 2026, 4:00 PM EDT
5.74
+0.10 (1.77%)
After-hours: Jun 1, 2026, 5:59 PM EDT

Company Description

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners.

The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets.

The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements.

It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Optimi Health Corp.
CountryCanada
Founded2020
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees8
CEODane Stevens

Contact Details

Address:
269 David Brown Way
Princeton, BC V0X 1W0
Canada
Phone778-761-4551
Websiteoptimihealth.ca

Stock Details

Ticker SymbolOPTH
ExchangeNASDAQ
Fiscal YearOctober - September
Reporting CurrencyCAD
CIK Code0002027329
CUSIP Number68405H308
ISIN NumberCA68405H3080

Key Executives

NamePosition
Dane StevensCo-Founder, Chief Executive Officer, Chief Marketing Officer and Director
John James WilsonCo-Founder and Chairman
Bryan Edward SafarikCo-Founder, Chief Operating Officer and Director
Dr. Preston A. ChaseChief Science Officer
Ann LittleHuman Resources Manager
Leah HodgesCorporate Secretary